Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
DG Shand
Observed names:
D G Shand,
D.G. Shand
Institution:
Duke Medical Center
Observed institutions:
Duke University,
Vanderbilt University,
Duke Medical Center,
King's College Hospital,
Newcastle University,
Vanderbilt University Medical Center
show all 6
OpenAlex ID:
A5111845214
Direct measurement of propranolol bioavailability during accumulation to steady‐state.
1978
·
AJ Wood
, K Carr
, et al.
·
British Journal of Clinical Pharmacology
·
123
PDF
Sex‐related differences in the plasma protein binding of lignocaine and diazepam.
1981
·
PA Routledge
, WW Stargel
, et al.
·
British Journal of Clinical Pharmacology
·
83
PDF
Determinants of plasma alpha 1‐acid glycoprotein (AAG) concentrations in health.
1985
·
PG Blain
, JC Mucklow
, et al.
·
British Journal of Clinical Pharmacology
·
81
PDF
Pharmacokinetics of propranolol: a review.
1976
·
D G Shand
·
PubMed
·
81
Propranolol disposition in renal failure.
1980
·
AJ Wood
, RE Vestal
, et al.
·
British Journal of Clinical Pharmacology
·
58
PDF
On the role of alpha 1‐acid glycoprotein in lignocaine accumulation following myocardial infarction.
1982
·
A Barchowsky
, DG Shand
, et al.
·
British Journal of Clinical Pharmacology
·
43
PDF
The effects of age and smoking on the plasma protein binding of lignocaine and diazepam.
1985
·
D Davis
, SH Grossman
, et al.
·
British Journal of Clinical Pharmacology
·
37
Lignocaine disposition in blood in epilepsy.
1981
·
PA Routledge
, WW Stargel
, et al.
·
British Journal of Clinical Pharmacology
·
33
PDF
Increased plasma propranolol binding in myocardial infarction.
1980
·
PA Routledge
, WW Stargel
, et al.
·
British Journal of Clinical Pharmacology
·
20
PDF
A free lignocaine index as a guide to unbound drug concentration.
1985
·
PA Routledge
, JD Lazar
, et al.
·
British Journal of Clinical Pharmacology
·
15
PDF
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]
1977
·
RA Branch
, DM Kornhauser
, et al.
·
British Journal of Clinical Pharmacology
·
15
Beta 1‐selective and non‐selective beta‐adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
1985
·
AA McLeod
, KD Knopes
, et al.
·
British Journal of Clinical Pharmacology
·
13
PDF
Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
1983
·
D G Shand
·
PubMed
·
10
Heparin administration increases plasma warfarin binding in man.
1979
·
PA Routledge
, TD Bjornsson
, et al.
·
British Journal of Clinical Pharmacology
·
8
PDF
Hemodynamic drug interactions.
1974
·
A S Nies
, D G Shand
, et al.
·
PubMed
·
7
Beta-adrenergic blocking drugs after acute myocardial infarction.
1982
·
D G Shand
·
PubMed
·
6
Reply
1978
·
G.R. Wilkinson
, A.J.J. Wood
, et al.
·
Gastroenterology
·
4
Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
1989
·
PA Routledge
, WW Stargel
, et al.
·
British Journal of Clinical Pharmacology
·
3
PDF
How should the proper dose of a beta blocker be determined?
1983
·
D G Shand
·
PubMed
·
3
Proceedings: Presystemic hepatic elimination.
1974
·
G R Wilkinson
, D G Shand
·
PubMed
·
3
The present status of propranolol.
1979
·
P A Routledge
, D G Shand
·
PubMed
·
1
Show more works
View as search
Works count:
21
Citation count:
647
H-index:
12
I10-index:
13
Year
Topic
Type